About Matt Vaughan
Form D filings for AmplifyBio from 2022 to 2023 list Matt Vaughan as director.
Matt Vaughan first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Matt Vaughan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matt Vaughan works with at each company, as listed on that company's latest Form D.
AmplifyBio, LLC · Form D, Nov 15, 2023
LT
Lewis Von Thaer
Director
SR
Shaun Rodriguez
Director
JG
James Ganjei
Chief Executive Officer
RN
Rohan Nirody
Director